Agenus Analyst Ratings
Buy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study Results
Agenus Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Merus (MRUS) and Iovance Biotherapeutics (IOVA)
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)
Agenus Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)
Agenus Shares Target Cut to $5, Analyst Maintains Buy Rating
Agenus Analyst Ratings
B. Riley Securities Trims Agenus' Price Target to $5 From $6 After Model Update, Maintains Buy Rating
Agenus Analyst Ratings
Agenus's Promising Botensilimab Leads to Buy Rating From Analyst Mayank Mamtani
Analysts Are Bullish on Top Healthcare Stocks: Agenus (AGEN), Zivo Bioscience (ZIVO)
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Regeneron (REGN) and Warby Parker (WRBY)
Positive Outlook for Agenus: Promising Clinical Progress and Effective Financial Management Drive Buy Rating
Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS), Agenus (AGEN) and OrthoPediatrics (KIDS)
B.Riley Financial Sticks to Its Buy Rating for Agenus (AGEN)
Agenus (AGEN) Receives a Buy From Robert W. Baird
B.Riley Financial Sticks to Their Buy Rating for Agenus (AGEN)
Robert W. Baird Keeps Their Buy Rating on Agenus (AGEN)